4//SEC Filing
Norden Gregory 4
Accession 0001802768-25-000107
CIK 0001802768other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:35 PM ET
Size
9.7 KB
Accession
0001802768-25-000107
Insider Transaction Report
Form 4
Norden Gregory
Director
Transactions
- Sale
Class A Ordinary Shares
2025-08-11$36.23/sh−33,500$1,213,749→ 194,848 total - Conversion
Class A Ordinary Shares
2025-08-08+144,660→ 228,348 total - Conversion
LP interests in RPI US Partners 2019, LP
2025-08-08−14,466→ 0 totalExercise: $0.00→ Class A Ordinary Shares (144,660 underlying)
Footnotes (3)
- [F1]These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with the exchange.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.40 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001405104
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:35 PM ET
- Size
- 9.7 KB